You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Express Scripts
Dow
Mallinckrodt

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for United States v. Cytogel Pharma, LLC (E.D. La. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

United States v. Cytogel Pharma, LLC (E.D. La. 2016)

Docket   Start Trial Date Filed 2016-08-19
Court District Court, E.D. Louisiana. Date Terminated
Cause 28:2201 Declaratory Judgment Assigned To Donna Sue Morgan
Jury Demand None Referred To
Parties ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND; CYTOGEL PHARMA, LLC; JAMES E ZADINA; THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND; UNITED STATES; UNITED STATES OF AMERICA
Patents 6,011,062
Attorneys Alissa Ann Digman; Arne M. Olson; Bryan C. Reuter; Eva J. Dossier; George Gabriel Gordon; Ian Charles Barras; Jonathan D. Loeb; Joseph Gribbin; Katherine Maeve Wyman; Matthew L. DePreter; Raymond Gerard Areaux; Richard C. Stanley; The Administrators of the Tulane Educational Fund; Walter W. Brown
Firms The Administrators of the Tulane Educational Fund; U. S. Department of Justice (Civil Division-1100 L St)
Link to Docket External link to docket
Small Molecule Drugs cited in United States v. Cytogel Pharma, LLC
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for United States v. Cytogel Pharma, LLC (E.D. La. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-10-25 395 Order on Motion to Dismiss 3d 1099, 1110, writ denied, 2011-0636 (La. 5/6/11), 62 So. 3d 127. 94 R. Doc. 279. 95 R. Doc. 220 at …obtained two patents, U.S. Patent Nos. 5,885,958 (“the ’958 Patent”) and 6,303,578 (“the ’578 Patent”), claiming…Cyt-1010 is covered by the ’958 Patent, the ’587 Patent, or both patents. 12 R. Doc. 1 at 5, 6, ¶ 16, 20…published patent application, like a patent, is readily available – the United States Patent and Trademark…’436 Patent to Tulane nor his using the ’958 at ’578 Patent compounds to develop the ’436 Patent constitute External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Merck
Johnson and Johnson
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.